It was wonderful having Dr. Funda Meric-Bernstam present Perlmutter Cancer Center at NYU Langone Health about “Optimizing Personalized Cancer Therapy.” #PancreaticCancer #clinicalresearch @fundamericbernstam NYU Grossman School of Medicine
The eagerly awaited #PFS data for #TrastuzumabDeruxtecan in #BiliaryCancer presented in #ESMO23 by #FundaMericBernstam from the DESTINY-PanTumor02
➡️mPFS 7.4 months (IHC3+)👍🏻
[Previously reported ORR 56%]
📸#3
ESMO - Eur. Oncology